Zobrazeno 1 - 10
of 432
pro vyhledávání: '"Rose-Zerilli M"'
Autor:
Sharpe BP; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Nazlamova LA; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; Early Cancer Institute, University of Cambridge, Department of Oncology, Box 197 Cambridge Biomedical Campus, Hills Road, Cambridge SB2 0XZ, UK., Tse C; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Johnston DA; Biomedical Imaging Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Thomas J; Bio-R Bioinformatics Research Facility, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Blyth R; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Pickering OJ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK., Grace B; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Harrington J; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Rajak R; University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK., Rose-Zerilli M; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Walters ZS; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK., Underwood TJ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; Bio-R Bioinformatics Research Facility, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Electronic address: tju@soton.ac.uk.
Publikováno v:
Cell reports methods [Cell Rep Methods] 2024 Dec 16; Vol. 4 (12), pp. 100909. Date of Electronic Publication: 2024 Nov 27.
Publikováno v:
Journal of Investigative Dermatology; December 2024, Vol. 144 Issue: 12, Number 12 Supplement 1 pS294-S294, 1p
Determinants of response to T‐cell stimulation by CD27 antibody therapy in lymphoma: The RiVa trial.
Autor:
Rose‐Zerilli, M. J., Buermann, L., Stanton, L., Wignall, C. M., Coleman, A. R., Thorne, K., Keyworth, N., Konn, Z., Turaj, A. H., McKay, P., Osborne, W., Linton, K., Medd, P., Collins, G. P., Keler, T., Yellin, M., Gentles, A., Griffiths, G., Lim, S. H.
Publikováno v:
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p281-283, 3p
Autor:
Sharpe BP; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Hayden A; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Manousopoulou A; Proteas Bioanalytics, Torrance, CA 90502, USA., Cowie A; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Walker RC; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Harrington J; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Izadi F; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK; Centre for NanoHealth, Swansea University Medical School, Singleton Campus, Swansea SA2 8PP, UK., Breininger SP; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Gibson J; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Pickering O; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Jaynes E; University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK., Kyle E; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Saunders JH; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK; Salford Royal NHS Foundation Trust, Salford M6 8HD, UK., Parsons SL; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK; Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK., Ritchie AA; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Clarke PA; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Collier P; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Mongan NP; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA; Biodiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG5 1PB, UK., Bates DO; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Yacqub-Usman K; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Garbis SD; Proteas Bioanalytics, Torrance, CA 90502, USA., Walters Z; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Rose-Zerilli M; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK., Grabowska AM; Ex Vivo Cancer Pharmacology Centre of Excellence, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK., Underwood TJ; School of Cancer Sciences, Faculty of Medicine, Room CS B2, MP824, Somers Cancer Research Building, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK. Electronic address: tju@soton.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Jun 21; Vol. 3 (6), pp. 100541.
Autor:
Abdelmotelb, A. M.1,2, Rose‐Zerilli, M. J.3, Barton, S. J.4, Holgate, S. T.1, Walls, A. F.1, Holloway, J. W.1,3
Publikováno v:
Clinical & Experimental Allergy. Jun2014, Vol. 44 Issue 6, p822-830. 9p.
Autor:
Larrayoz, M, Rose-Zerilli, M J J, Kadalayil, L, Parker, H, Blakemore, S, Forster, J, Davis, Z, Steele, A J, Collins, A, Else, M, Catovsky, D, Oscier, D G, Strefford, J C
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3dbad247effdf03634275d4efd2bf210
https://eprints.soton.ac.uk/400747/
https://eprints.soton.ac.uk/400747/
Autor:
Parker, H.1, Rose-Zerilli, M. J. J.1, Parker, A.2, Chaplin, T.3, Wade, R.4, Gardiner, A.2, Griffiths, M.5, Collins, A.6, Young, B. D.3, Oscier, D. G.2, Strefford, J. C.1 JCS@soton.ac.uk
Publikováno v:
Leukemia (08876924). Mar2011, Vol. 25 Issue 3, p489-497. 9p. 2 Diagrams, 3 Charts.
Autor:
Howell, W. M.1,2 martin.howell@nbs.nhs.uk, Rose-Zerilli, M. J.2, Theaker, J. M.3, Bateman, A. C.3
Publikováno v:
International Journal of Immunogenetics. Dec2005, Vol. 32 Issue 6, p367-373. 7p. 6 Charts.
Autor:
Nowicka M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Hilton LK; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada., Ashton-Key M; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Southampton University Hospitals NHS Foundation Trust, Southampton, United Kingdom., Hargreaves CE; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom., Lee C; Southampton University Hospitals NHS Foundation Trust, Southampton, United Kingdom., Foxall R; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Faculty of Medicine, Southampton, United Kingdom., Carter MJ; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Faculty of Medicine, Southampton, United Kingdom., Beers SA; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Faculty of Medicine, Southampton, United Kingdom., Potter KN; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom., Bolen CR; Genentech, Inc., South San Francisco, CA., Klein C; Roche Innovation Center Zurich, Schlieren, Switzerland., Knapp A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mir F; Royal Marsden Hospital, Sutton, United Kingdom., Rose-Zerilli M; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom., Burton C; St James's Institute of Oncology, Leeds, United Kingdom., Klapper W; Department of Hematopathology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Scott DW; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Sehn LH; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Vitolo U; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Martelli M; Department of Translational and Precision Medicine, Hematology, Sapienza University, Rome, Italy., Trneny M; 1st Medical Faculty, Charles University, Prague, Czech Republic; and., Rushton CK; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada; and., Slack GW; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Farinha P; BC Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada., Strefford JC; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom., Oestergaard MZ; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Morin RD; Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada; and., Cragg MS; School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.; Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton, Faculty of Medicine, Southampton, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2021 Aug 10; Vol. 5 (15), pp. 2945-2957.
Autor:
Garcia, E, Hayden, A, Birts, C, Britton, E, Cowie, A, Pickard, K, Mellone, M, Choh, C, Derouet, M, Duriez, P, Noble, F, White, MJ, Primrose, JN, Strefford, JC, Rose-Zerilli, M, Thomas, GJ, Ang, Y, Sharrocks, AD, Fitzgerald, RC, Underwood, TJ, MacRae, S, Grehan, N, Abdullahi, Z, De la Rue, R, Noorani, A, Elliott, RF, De Silva, N, Bornschein, J, O’Donovan, M, Contino, G, Yang, T-P, Chettouh, H, Crawte, J, Nutzinger, B, Edwards, PAW, Smith, L, Miremadi, A, Malhotra, S, Cluroe, A, Hardwick, R, Davies, J, Ford, H, Gilligan, D, Safranek, P, Hindmarsh, A, Sujendran, V, Carroll, N, Turkington, R, Hayes, SJ, Preston, SR, Oakes, S, Bagwan, I, Save, V, Skipworth, RJE, Hupp, TR, O’Neill, JR, Tucker, O, Taniere, P, Owsley, J, Crichton, C, Schusterreiter, C, Barr, H, Shepherd, N, Old, O, Lagergren, J, Gossage, J, Davies, A, Chang, F, Zylstra, J, Sanders, G, Berrisford, R, Harden, C, Bunting, D, Lewis, M, Cheong, E, Kumar, B, Parsons, SL, Soomro, I, Kaye, P, Saunders, J, Lovat, L, Haidry, R, Eneh, V, Igali, L, Welch, I, Scott, M, Sothi, S, Suortamo, S, Lishman, S, Beardsmore, D, Anderson, C, Smith, ML, Secrier, M, Eldridge, MD, Bower, L, Achilleos, A, Lynch, AG, Tavare, S
New biological tools are required to understand the functional significance of genetic events revealed by whole genome sequencing (WGS) studies in oesophageal adenocarcinoma (OAC). The MFD-1 cell line was isolated from a 55-year-old male with OAC wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::9ca52c74a9b86e3cbb9519ef47f7c8ae
http://hdl.handle.net/10044/1/42756
http://hdl.handle.net/10044/1/42756